Novartis India Ltd (NOVARTIND) — Announcement | 12 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Audio recording of analyst call made publicly available
💡 Investor Takeaway
Shareholders can access the full discussion to assess management commentary and market outlook.

Novartis India announced that the audio recording of its September 11, 2026 analyst call is now available on its website, confirming no unpublished price sensitive information was discussed.

📄 View Original Announcement (PDF)

About Novartis India Ltd (NOVARTIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,908.88 Cr P/E: 60.4 ROE: 11.9% ROCE: 16.7%

View full NOVARTIND stock details →

📡 Get AI alerts when NOVARTIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NOVARTIND — Free

📊 More NOVARTIND filings

See all NOVARTIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NOVARTIND files new disclosures

Track NOVARTIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NOVARTIND — Free

Free account · 2 AI queries/day